Assessing the potential clinical utility of transplantations of neural and mesenchymal stem cells for treating neurodegenerative diseases

Methods in Molecular Biology

Volumn 879, Issue , 2012, Pages 147-164

  Lescaudron, Laurent ^a,b,c   Boyer, C ^a,b,d   Bonnamain, Virginie ^a,b,e   Fink, K D ^a,b,f   Leveque X ^a,b,c   Rossignol, J ^f,g   Nerriere Daguin V ^a,b   Malouet, A C ^a,b   Lelan, F ^a,b   Dey, N D ^g   Michel Monigadon, D ^a,h   Lu, M ^f   Neveu, I ^a,b,c   Von Horsten S ⁱ   Naveilhan, P ^a,b,c   Dunbar, G L ^f,g  

^a INSERM   (France)

^b HÔTEL DIEU   (France)

^c UNIVERSITÉ DE NANTES   (France)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^e LERNER RESEARCH INSTITUTE   (United States)

^f CENTRAL MICHIGAN UNIVERSITY   (United States)

^g Field Neurosciences Institute   (United States)

^h UNIVERSITY HOSPITAL   (Switzerland)

ⁱ UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Brain transplantation; Mesenchymal stem cells; Neural stem cells; Stem cell isolation

Indexed keywords

ANIMAL; ARTICLE; CELL CULTURE; CELL SEPARATION; CYTOLOGY; DEGENERATIVE DISEASE; MESENCHYMAL STEM CELL; METHODOLOGY; NEURAL STEM CELL; RAT; SPRAGUE DAWLEY RAT; STEM CELL TRANSPLANTATION;

ANIMALS; CELL SEPARATION; CELLS, CULTURED; MESENCHYMAL STEM CELLS; NEURAL STEM CELLS; NEURODEGENERATIVE DISEASES; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL TRANSPLANTATION;

ANIMALIA; RODENTIA;

EID: 84861807006     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-815-3_10     Document Type: Article

References (15)

1. Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710-719
2. Hagell P, Piccini P, Bjorklund A, Brundin P, Rehncrona S, Widner H, Crabb L, Pavese N, Oertel WH, Quinn N, Brooks DJ, Lindvall O (2002) Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 5:627-628
3. Svendsen CN, Smith AG (1999) New prospects for human stem-cell therapy in the nervous system. Trends Neurosci 22:357-364
4. Vazey EM, Chen K, Hughes SM, Connor B (2006) Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease. Exp Neurol 199: 384-396
5. Michel-Monigadon D, Bonnamain V, Nerriére-Daguin V, Dugast AS, Lévéque X, Plat M, Venturi E, Brachet P, Anegon I, Vanhove B, Neveu I, Naveilhan P (2011) Trophic and immunoregulatory properties of neural precursor cells: benefit for intracerebral transplantation. Exp Neurol 230:35-47
6. Pluchino S, Zanotti L, Rossi B, Brambilla E, Ottoboni L, Salani G, Martinello M, Cattalini A, Bergami A, Furlan R, Comi G, Constantin G, Martino G (2005) Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436:266-271
7. Bonnamain V, Neveu I, Naveilhan P (2011) In vitro analyses of the immunosuppressive properties of neural stem/progenitor cells using anti-CD3/CD28-activated T cells. Methods Mol Biol 677:233-243
8. Dunbar GL, Sandstrom MI, Rossignol J, Lescaudron L (2006) Neurotrophic enhancers as therapy for behavioral deficits in rodent models of Huntington's disease: use of gangliosides, substituted pyrimidines, and mesenchymal stem cells. Behav Cogn Neurosci Rev 5:63-79
9. Dey ND, Bombard MC, Roland BP, Davidson S, Lu M, Rossignol J, Sandstrom MI, Skeel RL, Lescaudron L, Dunbar GL (2010) Genetically engineered mesenchymal stem cells reduce behavioral deficits in the YAC 128 mouse model of Huntington's disease. Behav Brain Res 214:193-200
10. Rossignol J, Boyer C, Lévéque X, Fink KD, Thinard R, Blanchard F, Dunbar GL, Lescaudron L (2011) Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes. Behav Brain Res 217:369-378
11. Rossignol J, Boyer C, Thinard R, Remy S, Dugast AS, Dubayle D, Dey ND, Boeffard F, Delecrin J, Heymann D, Vanhove B, Anegon I, Naveilhan P, Dunbar GL, Lescaudron L (2009) Mesenchymal stem cells induce a weak immune response in the rat striatum after allo or xenotransplantation. J Cell Mol Med 13: 2547-2558
12. Michel DC, Nerriére-Daguin V, Josien R, Brachet P, Naveilhan P, Neveu I (2006) Dendritic cell recruitment following xenografting of pig fetal mesencephalic cells into the rat brain. Exp Neurol 202:76-84
13. von Hörsten S, Schmitt I, Nguyen HP, Holzmann C, Schmidt T, Walther T, Bader M, Pabst R, Kobbe P, Krotova J, Stiller D, Kask A, Vaarmann A, Rathke-Hartlieb S, Schulz JB, Grasshoff U, Bauer I, Vieira-Saecker AM, Paul M, Jones L, Lindenberg KS, Landwehrmeyer B, Bauer A, Li XJ, Riess O (2003) Transgenic rat model of Huntington's disease. Hum Mol Genet 12:617-624
14. Lelan F, Boyer C, Thinard R, Rémy S, Usal C, Tesson L, Anegon I, Neveu I, Damier P, Naveilhan P, Lescaudron L (2011) Effects of human alpha-synuclein A53T-A30P mutations on SVZ and local olfactory bulb cell proliferation in a transgenic rat model of Parkinson disease. Parkinsons Dis 2011:987084
15. Danielyan L, Schäfer R, von Ameln-Mayerhofer A, Buadze M, Geisler J, Klopfer T, Burkhardt U, Proksch B, Verleysdonk S, Ayturan M, Buniatian GH, Gleiter CH, Frey WH 2nd (2009) Intranasal delivery of cells to the brain. Eur J Cell Biol 88:315-324